Characterisation of a Vitrocell® VC 10 in vitro smoke exposure system using dose tools and biological analysis

Chemistry Central Journal

Volumn 7, Issue 1, 2013, Pages

  Thorne, David ^a   Kilford, Joanne ^b   Payne, Rebecca ^b   Adamson, Jason ^a   Scott, Ken ^a   Dalrymple, Annette ^a   Meredith, Clive ^a   Dillon, Deborah ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b Department of Genetic and Molecular Toxicology   (United Kingdom)

Author keywords

CO; Dosimetry; In vitro; Particle deposition; QCM; Quartz crystal microbalance; Vitrocell ; Whole smoke

Indexed keywords

EID: 84883277900     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-7-146     Document Type: Article

References (32)

1. Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the smoke: the science base for tobacco harm reduction-executive summary. Tob Control 2001, 10:189-195. 10.1136/tc.10.2.189, 1747561, 11387543.
2. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003, 54:113-129. 10.1146/annurev.med.54.101601.152209, 12359824.
3. Levitz JS, Bradley TP, Golden AL, Levitz JS, Bradley TP, Golden AL. Overview of smoking and all cancers. Med Clin North Am 2004, 88:1655-1675. 10.1016/j.mcna.2004.07.005, 15464119.
4. Perfetti TA, Rodgman A. The complexity of tobacco and tobacco smoke. Beitraege zur Tabakforschung International 2011, 24:215-232.
5. Clunes L, Bridges B, Alexis N, Tarran R. In vivo versus in vitro airway surface liquid nicotine levels following cigarette smoke exposure. J Anal Toxicol 2008, 32:201-207. 10.1093/jat/32.3.201, 2994604, 18397571.
6. Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control 2003, 12:424-430. 10.1136/tc.12.4.424, 1747794, 14660781.
7. Baker RR. The generation of formaldehyde in cigarettes - overview and recent experiments. Food Chem Toxicol 2006, 44:1799-1822. 10.1016/j.fct.2006.05.017, 16859820.
8. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997, 50:307-364. 10.1080/009841097160393, 9120872.
9. Aufderheide M, Knebel JW, Ritter D. An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Exp Toxicol Pathol 2003, 55:51-57. 10.1078/0940-2993-00298, 12940629.
10. Scian MJ, Oldham MJ, Kane DB, Edmiston JS, McKinney WJ. Characterization of a whole smoke in vitro exposure system (Burghart Mimic Smoker-01). Inhal Toxicol 2009, 21:234-243. 10.1080/08958370802482515, 19016061.
11. Phillips J, Kluss B, Richter A, Massey E. Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. Altern Lab Anim 2005, 33:239-248.
12. Nara H, Fukano Y, Nishino T, Aufderheide A. Detection of the cytotoxicty of waterinsoluble fraction of cigarette smoke by direct exposure to cultures cells at an air-liquid interface. Exp Toxicol Pathol 2013, 65(5):683-688. 10.1016/j.etp.2012.08.004, 22999638.
13. Newland N, Richter A. Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial cells. Toxicol In Vitro 2008, 22:1782-1788. 10.1016/j.tiv.2008.07.009, 18684396.
14. Crooks I, Dillon D, Scott K, Ballantyne M, Meredith C. The effect of long term storage on tobacco smoke particulate matter in in vitro genotoxicity and cytotoxicity assays. Regul Toxicol Pharmacol 2013, 65:196-200. 10.1016/j.yrtph.2012.11.012, 23220485.
15. Okuwa K, Tanaka M, Fukano Y, Nara H, Nishijima Y, Nishino T. In vitro micronucleus assay for cigarette smoke using a whole smoke exposure system: a comparison of smoking regimens. Exp Toxicol Pathol 2010, 62:433-440. 10.1016/j.etp.2009.06.002, 19560909.
16. Muller L, Gasser M, O'raemy D, Herzog F, Brandenberger C, Schmid O, Gehr P, Rothen-Rutishauser B, Clift M. Realistic exposure methods for investigating the interaction of nanoparticles with the lung at the air-liquid interface. Journal of In Vitro Science 2011, 1:30-64.
17. Zhang W, Case S, Bowler RP, Martin RJ, Jiang D, Chu W. Cigarette smoke modulates PGE(2) and host defence against Moraxella catarrhalis infection in human airway epithelial cells. Respirology 2011, 16:508-516. 10.1111/j.1440-1843.2010.01920.x, 21199162.
18. Gualerzi A, Sciarabba M, Tartaglia G, Sforza C, Donetti E. Acute effects of cigarette smoke on three-dimensional cultures of normal human oral mucosa. Inhal Toxicol 2012, 24:382-389. 10.3109/08958378.2012.679367, 22564096.
19. Adamson J, Azzopardi D, Errington G, Dickens C, McAughey J, Gaça M. Assessment of an in vitro whole cigarette smoke exposure system: the borgwaldt RM20S 8-syringe smoking machine. Chemistry Cenrtal Journal 2011, 5:50.
20. Adamson J, Hughes S, Azzopardi D, McAughey J, Gas{cyrillic with descender}a M. Real-time assessment of cigarette smoke particle deposition in vitro. Chemistry Central Journal 2012, 6:98. 10.1186/1752-153X-6-98, 3443673, 22958446.
21. Scian MJ, Oldham MJ, Miller JH, Kane DB, Edmiston JS, McKinney WJ. Chemical analysis of cigarette smoke particulate generated in the MSB-01 in vitro whole smoke exposure system. Inhal Toxicol 2009, 21:1040-1052. 10.1080/08958370802712705, 19772483.
22. Ritter D, Knebel JW, Aufderheide M. Comparative assessment of toxicities of mainstream smoke from commercial cigarettes. Inhal Toxicol 2004, 16:691-700. 10.1080/08958370490476659, 15371057.
23. Aufderheide M, Gressmann H. A modified Ames assay reveals the mutagenicity of native cigarette mainstream smoke and its gas vapour phase. Exp Toxicol Pathol 2007, 58:383-392. 10.1016/j.etp.2007.02.002, 17555953.
24. Adamson J, Thorne D, Dalrymple A, Dillon D, Meredith C. Cigarette smoke deposition in a Vitrocell® exposure module: real-time quantification in vitro using quartz crystal microbalances. Chemistry Central 2013, 7:50.
25. Thorne D, Adamson A. A review of in vitro cigarette smoke exposure systems. Exp Toxicol Pathol 2013, In Press.
26. Adamson J, Thorne D, McAughey J, Dillon D, Meredith C. Quantificantion of cigarette smoke particle deposition in vitro usin a triplicate quartz crystal microbalance exposure chamber. Biomed Research International 2013, Article ID 685074.
27. Andreoli C, Gigante D, Nunziata A. A review of in vitro methods to assess the biologcial activity of tobacco smoke with the aim of resucing the toxicology of smoke. Toxicol In Vitro 2003, 17:587-594. 10.1016/S0887-2333(03)00091-2, 14599449.
28. Thorne D, Wilson J, Kumaravel TS, Massey ED, McEwan M. Measurement of oxidative DNA damage induced by mainstream cigarette smoke in cultured NCI-H292 human pulmonary carcinoma cells. Mutat Res 2009, 673:3-8. 10.1016/j.mrgentox.2008.11.008, 19100859.
29. Aufderheide M, Gressman H. Mutagenicity of native cigarette mainstream smoke and its gas/vapour phase by use of different tester stains and cigarettes in Ames assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2008, 656:82-87.
30. Hagiwara Y, Wantanabe M, Oda Y, Sofuni T, Nohmi T. Specificity and sensitivity of Salmonella typhimurium YG1041 and YG1042 strains possesing elevated levels of both nitroreductase and acetyltransferase activity. Mutation Research/Environmental Mutagenesis and Related Subjects 1993, 291:171-180.
31. Maron D, Ames B. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983, 113:173-215. 10.1016/0165-1161(83)90010-9, 6341825.
32. De Serres F, Shelby M. Recommendations on data production and analysis using the Salmonella/microsome mutagenicity assay. Mutat Res 1979, 64:159-165.